Fig. 2. Development of leoligin analogs as NF-κB inhibitors. NF-κB inhibition is expressed by their IC₅₀ values. Inhibition of EC proliferation is given as the reduction in cell number ± standard error of the mean at 30 μM concentration with respect to the negative control (100%).